The unmet need
Neuropathic pain can be persistent and difficult to manage. Systemic treatments may not provide adequate relief for all patients and may cause unwanted effects.
Exploring long-lasting, nerve-targeted therapeutic activity for severe or refractory localized neuropathic pain.

Neuropathic pain can be persistent and difficult to manage. Systemic treatments may not provide adequate relief for all patients and may cause unwanted effects.
NVO-801 is being developed around perineural AAV delivery of a locally acting therapeutic payload. The goal is to modulate pain signaling near a selected peripheral nerve while minimizing systemic exposure.
NVO-801 remains investigational. Preclinical proof-of-concept work informs further research, but durable analgesic efficacy and safety have not been established in human patients.
Investigational research program. Preclinical observations do not demonstrate clinical safety or efficacy.
We welcome conversations with scientific, clinical and strategic partners.